<DOC>
	<DOCNO>NCT01492647</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability JNJ 10229570-AAA single topical application JNJ 10229570-AAA 1.2 % 3.6 % cream Japanese participant acne .</brief_summary>
	<brief_title>A Study JNJ 10229570-AAA Evaluate Safety Tolerability Japanese Participants With Acne Vulgaris</brief_title>
	<detailed_description>This randomize ( drug assign chance like flip coin ) , double blind ( neither physician patient know name assigned drug ) , single dose ascend study JNJ 10229570-AAA Japanese participant acne . The study evaluate safety pharmacokinetics ( [ PK ] drug absorb body , distribute within body remove body time ) M1 ( active metabolite ) total eighteen ( 18 ) participant enrol study , nine ( 9 ) group . Each participant receive JNJ 10229570-AAA 1.2 % , 3.6 % vehicle cream formulation 2.5 mL application , face , neck , shoulder , chest upper back area . The investigational product wash blood sample 24 hour application . Safety tolerability evaluate throughout study topical dermatological assessment do dermatologist . The total duration study maximum 35 day .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Have Acne vulgaris , present least inflammatory lesion face Body mass index 18.0 30.0 kg/m2 ( inclusive ) , body weight less 50 kg ( man ) 45 kg ( woman ) Blood pressure 90 140 mmHg systolic ( inclusive ) , high 90 mmHg diastolic Electrocardiogram ( ECG ) consistent normal cardiac conduction function Nonsmoker Adequate contraception method men woman . If woman , must negative pregnancy test Signed informed consent document History current clinically significant medical illness investigator considers exclude participant could interfere interpretation study result Clinically significant abnormal value hematology , biochemistry urinalysis Clinically significant abnormal physical examination , vital sign ECG Use prescription nonprescription medication within 14 day study treatment History drug alcohol abuse within past 5 year Drug allergy drug hypersensitivity Blood donation , depend volume blood collection Positive test human immunodeficiency virus ( HIV ) , hepatitis B C , syphilis Dermatological disease application site Photosensitivity Exposure excessive chronic ultraviolet ( UV ) radiation ( i.e. , sunbathe , tan salon use , phototherapy ) within 4 week prior study treatment plan study period</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Acne vulgaris</keyword>
	<keyword>JNJ 10229570-AAA</keyword>
	<keyword>Japanese patient</keyword>
	<keyword>Topical treatment</keyword>
</DOC>